Skip to main content
Quest Diagnostics

The Prevalence and Phenotype of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population in Trinidad

ENDO 2026

Chicago, IL, June 13-16,  2026

Poster presentation: The Prevalence and Phenotype of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population in Trinidad

Authors: Voorhies KR , Bi , Vaidya A, McPhaul MJ, Marcelli M

Medical Specialty: Endocrinology, Cardiology, Cardiovascular disease, Women's health, OB/GYN

Related content

Audio Podcast
Laboratory Assessment in PCOS Diagnosis and Management
On-Demand Webinar
Demystifying the Diagnosis of Polycystic Ovary Syndrome
On-Demand Webinar
The Link Between Reproductive Abnormalities and Cardiometabolic Conditions
Test FAQ
Ovarian Assessment Report (OAR)
Conference Presentation
The Prevalence and Phenotype of PCOS in a Community-based Population in Sub-Sahara Africa: The Nigeria-PEP Study

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.